Guggenheim lowered the firm’s price target on Neogen (NEOG) to $13 from $15 and keeps a Buy rating on the shares. While a post-integration Neogen “seems to be in view,” a CEO change and uncertain macro backdrop could extend near-term growth choppiness, the analyst tells investors.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG: